Abstract
Neuroinflammatory processes are a common epiphenomenon for a number of neurological and neurodegenerative diseases. Besides microglia, astrocytes are implicated in brain inflammation in response to harmful stimuli and pathological processes. Bacterial endotoxins can induce the synthesis and release of proinflammatory mediators, i.e., cytokines and chemokines, by astroglia. In this study, we have investigated the effect of lipopolysaccharide (LPS) treatment on the expression of enzymes of prostanoid synthesis and degradation in cultured mouse cortical astrocytes using an Affymetrix Gene Chip array, quantitative reverse transcriptase polymerase chain reaction (RT-PCR), and an enzyme-immunosorbent assay. LPS treatment induced an upregulation of enzymes responsible for prostaglandin E2 synthesis, a downregulation of enzymes that catalyzes prostaglandin E2 (PGE2) degradation and production of proinflammatory leukotrienes. Changes in enzyme expression were accompanied by a highly significant increase in extracellular PGE2. Our data demonstrate that astrocytes are directly involved in the complex regulation of proinflammatory prostanoids in the CNS under pathological processes, thus being of potential interest as targets for therapeutical interventions. Further studies are required to unravel the different roles and interactions between astroglia and other cells of the brain-intrinsic innate immune system during inflammation.
Similar content being viewed by others
Abbreviations
- AA:
-
arachidonic acid
- ALOX-5:
-
5-lipoxygenase
- CNS:
-
central nervous system
- COX:
-
cyclooxygenase
- DEX:
-
dexamethasone
- DNA:
-
deoxyribonucleic acid
- EDTA:
-
ethylenediamine tetraacetic acid
- EIA:
-
enzyme immunosorbent assay
- GFAP:
-
glial fibrillary acidic protein
- HPGD:
-
15-hydroxy prostaglandin dehydrogenase
- HPLC:
-
high-performance liquid chromatography
- HPRT:
-
hypoxanthin-guanin-phosphoribosyl-transferase
- IL:
-
interleukin
- LBP:
-
lipopolysaccharide binding protein
- LPS:
-
lipopolysaccharides
- LTB:
-
leukotrienes
- Myd88:
-
myeloid differentiation factor 88
- NS-398:
-
N-(2-cyclohexyloxy-4-nitrophenyl)-methanesulfonamide
- OD:
-
optical density
- PCR:
-
polymerase chain reaction
- PG:
-
prostaglandin
- PGDS:
-
prostaglandin D2 synthase
- PGE2 :
-
prostaglandin E2
- PGER:
-
prostaglandin E2 receptor
- PTGES:
-
prostaglandin E synthase
- PTGIS:
-
prostacyclin synthase
- PTGIR:
-
prostacyclin receptor
- PLA2 :
-
phospholipase A2 (c, cytosolic, i, calcium-dependent, s, secretory)
- RNA:
-
ribonucleic acid
- RT:
-
reverse transcription
- SDS:
-
sodium dodecyl sulfate
- TBXAS:
-
thromboxane-A synthase
- TBXs:
-
thromboxanes
- TLR-4:
-
toll-like receptor 4
- TNFα:
-
tumor necrosis factor α
References
Aloisi, F., Ria, F., & Adorini, L. (2000). Regulation of T-cell responses by CNS antigen-presenting cells: different roles for microglia and astrocytes. Immunology Today, 21, 141–147.
Darlington, C. L. (2005). Astrocytes as targets for neuroprotective drugs. Current Opinion in Investigational Drugs, 6, 700–703.
Farina, C., Aloisi, F., & Meinl, E. (2007). Astrocytes are active players in cerebral innate immunity. Trends in Immunology, 28, 138–145.
Farooqui, A. A., Horrocks, L. A., & Farooqui, T. (2007). Modulation of inflammation in brain: A matter of fat. Journal of Neurochemistry, 101, 577–599.
Fisher, L., Samuelsson, M., Jiang, Y., et al. (2007). Targeting cytokine expression in glial cells by cellular delivery of an NF-κB Decoy. Journal of Molecular Neuroscience, 31, 209–220.
Gebicke-Haerter, P. J. (2001). Microglia in neurodegeneration: Molecular aspects. Microscopy Research and Technique, 54, 47–58.
Gentleman, R. C., Carey, V. J., Bates, D. M., et al. (2004). Bioconductor: Open software development for computational biology and bioinformatics. Genome Biology, 5, R:80.
Gordon, G. R., Mulligan, S. J., & MacVicar, B. A. (2007). Astrocyte control of the cerebrovasculature. Glia, 55, 1214–1221.
Harizi, H., & Gualde, N. (2005). The impact of eicosanoids on the crosstalk between innate and adaptive immunity: The key roles of dendritic cells. Tissue Antigens, 65, 507–514.
Haydon, P. G., & Carmignoto, G. (2006). Astrocyte control of synaptic transmission and neurovascular coupling. Physiological Reviews, 86, 1009–1031.
Iadecola, C., Niwa, K., Nogawa, S., et al. (2001). Reduced susceptibility to ischemic brain injury and N-methyl-D-aspartate-mediated neurotoxicity in cyclooxygenase-2-deficient mice. Proceedings of the National Academy of Sciences of the United States of America, 98, 1294–1299.
Institoris, A., Farkas, E., Berczi, S., Sule, Z., & Bari, F. (2007). Effects of cyclooxygenase (COX) inhibition on memory impairment and hippocampal damage in the early period of cerebral hyperfusion in rats. European Journal of Pharmacology, 57, 29–38.
Ivanov, A. I., & Romanovsky, A. A. (2004). Prostaglandin E2 as a mediator of fever: Synthesis and catabolism. Frontiers in Bioscience, 9, 1977–1993.
Jin, J., Shie, F. S., Liu, J., Wang, Y., Davis, J., Schantz, A. M., et al. (2007). Prostaglandin E2 receptor subtype 2 (EP2) regulates microglial activation and associated neurotoxicity induced by aggregated alpha-synuclein. Journal of Neuroinflammation, 4, 4:2.
Kampmann, M., & Mey, J. (2007). Retinoic acid enhances Erk phosphorylation in the chick retina. Neuroscience Letters, 426, 18–22.
Karakaja, S., Kipp, M., & Beyer, C. (2007). Oestrogen regulates the expression and function of dopamine transporters in astrocytes of the nigrostriatal system. Journal of Neuroendocrinology, 19, 682–690.
Kawano, T., Anrather, J., Zhou, P., Park, I., Wang, G., Frys, K. A., et al. (2006). Prostaglandin E2 EP1 receptors: Downstream effectors of COX-2 neurotoxicity. Natural Medicines, 12, 225–229.
Kipp, M., Karakaya, S., Johann, S., Kampmann, E., Mey, J., & Beyer, C. (2007). Oestrogen and progesterone reduce lipopolysaccharide-induced expression of tumor necrosis factor-alpha and interleukin-18 in midbrain astrocytes. Journal of Neuroendocrinology, 19, 819–22.
Kipp, M., Karakaya, S., Pawlak, J., Araujo-Wright, G., Arnold, S., & Beyer, C. (2006). Estrogen and the development and protection of midbrain dopaminergic neurons: concerted action of a multitude of signals, protective molecules, and growth factor. Frontiers in Neuroendocrinology, 27, 376–390.
Kis, B., Snipes, J. A., Gaspar, T., Lenzser, G., Tulbert, C. D., & Busija, D. W. (2006). Cloning of cyclooxygenases-1b (putative COX-) in mouse. Inflammation Research, 55, 274–278.
Klivenyi, P., Kiaei, M., Gardian, G., Calingasan, N. Y., & Beal, M. F. (2004). Additive neuroprotective effects of creatine and cyclooxygenase 2 inhibitors in a transgenic mouse model of amyotrophic lateral sclerosis. Journal of Neurochemistry, 88, 576–582.
Lucas, S. M., Rothwell, N. J., & Gibson, R. M. (2006). The role of inflammation in CNS injury and disease. British Journal of Pharmacology, 147, 232–240.
Levy, E., & Fleisher-Berkovich, S. (2007). Regulation of glial cyclooxygenases by bradykinin. Peptides, 28, 845–850.
Minghetti, L. (2004). Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases. Journal of Neuropathology and Experimental Neurology, 63, 901–910.
Minghetti, L., & Levi, G. (1998). Microglia as effector cells in brain damage and repair: Focus on prostanoids and nitric oxide. Progress in Neurobiology, 54, 99–125.
Murakami, M., & Kudo, I. (2002). Phospholipase A2. Journal of Biochemistry, 131, 285–292.
Murakami, M., Naraba, H., Tanioka, T., et al. (2000). Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2. Journal of Biological Chemistry, 275, 32783–32792.
Murphy, S., Pearce, B., Jeremy, J., & Dandona, P. (1988). Astrocytes as eicosanoid-producing cells. Glia, 1, 241–245.
Narumiya, S. (2003). Prostanoids in immunity: Roles revealed by mice deficient in their receptors. Life Sciences, 74, 391–395.
O’Banion, M. K., & Finch, C. E. (1996). Inflammatory mechanisms and anti-inflammatory therapy in Alzheimer’s disease. Neurobiology of Aging, 17, 669–671.
Palsson-McDermott, E. M., & O’Neill, L. A. J. (2004). Signal transduction by the lipopolysaccharide receptor, Toll-like receptor 4. Immunology, 113, 153–162.
Pawlak, J., & Beyer, C. (2005). Developmental expression of MNAR mRNA in the mouse brain. Cell & Tissue Research, 320, 545–549.
Pawlak, J., Karolczak, M., & Beyer, C. (2005). Estrogen receptor-alpha is associated with the plasma membrane of astrocytes and coupled to the MAP/Src-kinase pathway. Glia, 50, 270–275.
Pellerini, L., Bouzier-Sore, A. K., Aubert, A., Serres, S., Merle, M., Costalat, R., et al. (2007). Activity-dependent regulation of energy metabolism by astrocytes: an update. Glia, 55, 1251–1262.
Phillis, J. W., Horrocks, L. A., & Farooqui, A. A. (2006). Cyclooxygenases, lipoxygenases, and epoxygenases in CNS: Their role and involvement in neurological disorders. Brain Research Reviews, 52, 201–243.
Pistritto, G., Franzese, O., Pozzoli, G., et al. (1999). Bacterial lipopolysaccharide increases prostaglandin production by rat astrocytes via inducible cyclooxygenase: Evidence for the involvement of nuclear factor kB. Biochemical and Biophysical Research Communications, 263, 570–574.
Pompl, P. N., Ho, L., Bianch, M., McManus, T., Qin, W., & Pasinetti, G. M. (2003). A therapeutic role for cyclooxygenase-2 inhibitor in a transgenic mouse model of amyotrophic sclerosis. FASEB Journal, 17, 725–727.
Richards, J. A., Petrel, T. A., & Brueggemeier, R. W. (2002). Signaling pathways regulating aromatase and cyclooxygenases in normal and malignant breast cells. Journal of Steroid Biochemistry and Molecular Biology, 80, 203–212.
Samad, T. A., Moore, K. A., Sapirstein, A., et al. (2001). Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature, 410, 471–475.
Schwartz, M., Butovsky, O., Bruck, W., & Hanisch, U. K. (2006). Microglial phenotype: Is the commitment reversible? Trends in Neurosciences, 29, 68–74.
Shaftel, S. S., Olschowka, J. A., Hurley, S. D., Moore, A. H., & O’Banion, M. K. (2003). COX-3: A splice variant of cyclooxygenase-1 in mouse neuronal tissue and cells. Journal of Molecular Brain Research, 119, 213–215.
Shoji, M., Tanabe, N., Mitsui, N., Tanaka, H., Suzuki, N., Takeichi, O., et al. (2006). Lipopolysaccharide stimulates the production of prostaglandin E2 and the receptor Ep4 in osteoblasts. Life Sciences, 78, 2012–2018.
Sun, G. Y., Up, J., Jensen, M. D., & Simonyi, A. (2004). Phospholipase A2 in the central nervous system: implications for neurodegenerative diseases. Journal of Lipid Research, 45, 205–213.
Takuma, K., Baba, A., & Matsuda, T. (2004). Astrocyte apoptosis: Implication for neuroprotection. Progress in Neurobiology, 72, 111–117.
Teismann, P., Thieu, K., Choi, D. K., et al. (2003). Cyclooxygenase-2 is instrumental in Parkinson’s disease neurodegeneration. Proceedings of the National Academy of Sciences of the United States of America, 100, 5473–5478.
Tzeng, S. F., Hsiao, H. Y., & Mak, O. T. (2005). Prostaglandins and cyclooxygenases in glial cells during brain inflammation. Current Drug Targets Inflammation and Allergy, 4, 335–340.
Uematsu, S., Matsumoto, M., Takeda, K., & Akira, S. (2002). Lipopolysaccharide-dependent prostaglandin E(2) production is regulated by the glutathione-dependent prostaglandin E(2) synthase gene induced by the Toll-like receptor 4/MyD88/NF-IL6 pathway. Journal of Immunology, 168, 5811–5816.
Yermakova, A., & O’Banion, M. K. (2000). Cyclooxygenases in the central nervous system: Implications for treatment of neurological disorders. Current Pharmaceutical Design, 6, 1755–1776.
Author information
Authors and Affiliations
Corresponding author
Additional information
Sonja Johann and Eric Kampmann contributed equally.
Rights and permissions
About this article
Cite this article
Johann, S., Kampmann, E., Denecke, B. et al. Expression of Enzymes Involved in the Prostanoid Metabolism by Cortical Astrocytes after LPS-induced Inflammation. J Mol Neurosci 34, 177–185 (2008). https://doi.org/10.1007/s12031-007-9028-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12031-007-9028-4